scholarly article | Q13442814 |
P356 | DOI | 10.1002/CHIR.22563 |
P698 | PubMed publication ID | 26708721 |
P2093 | author name string | Gergő Tóth | |
Zoltán-István Szabó | |||
Daniela-Lucia Muntean | |||
Levente Szőcs | |||
Béla NoszáL | |||
P2860 | cites work | Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide | Q24614147 |
Thalidomide analogues as anticancer drugs | Q24670383 | ||
Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide | Q27684738 | ||
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue | Q33459422 | ||
Thalidomide-a notorious sedative to a wonder anticancer drug | Q33956871 | ||
Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide. | Q34058602 | ||
Thalidomide: the tragedy of birth defects and the effective treatment of disease | Q34179690 | ||
Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man. | Q34646752 | ||
Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs | Q34661167 | ||
Population pharmacokinetics of pomalidomide | Q35565182 | ||
The thalidomide saga | Q36763353 | ||
Chemometric experimental design based optimization techniques in capillary electrophoresis: a critical review of modern applications | Q36957551 | ||
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses | Q37619631 | ||
Chiral selectors in CE: recent developments and applications (2012-mid 2014). | Q38255033 | ||
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration | Q43019139 | ||
Chiral inversion of the second generation IMiD CC-4047 (ACTIMID ) in human plasma and phosphate-buffered saline | Q44383574 | ||
The evolution of thalidomide and its IMiD derivatives as anticancer agents | Q44824886 | ||
A double-blind study of the sedative effects of the thalidomide enantiomers in humans | Q48766029 | ||
Investigation of the enantiomerization barriers of the phthalimidone derivatives EM12 and lenalidomide by dynamic electrokinetic chromatography. | Q50994881 | ||
A validated UPLC-MS/MS assay using negative ionization mode for high-throughput determination of pomalidomide in rat plasma. | Q53628417 | ||
Modeling and simulation to probe the pharmacokinetic disposition of pomalidomide R- and S-enantiomers. | Q55058282 | ||
Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatography | Q55968708 | ||
Investigation of the in vitro biotransformation and simultaneous enantioselective separation of thalidomide and its neutral metabolites by capillary electrophoresis | Q71489111 | ||
Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues | Q71742426 | ||
Investigation of the stereoselective in vitro biotransformation of thalidomide using a dual cyclodextrin system in capillary electrophoresis | Q72990981 | ||
Enantioseparation of thalidomide and its hydroxylated metabolites using capillary electrophoresis with various cyclodextrins and their combinations as chiral buffer additives | Q73024844 | ||
Identification and characterization of related substances in pomalidomide by hyphenated LC-MS techniques | Q85321779 | ||
P433 | issue | 3 | |
P921 | main subject | chirality | Q214514 |
enantiomer | Q494483 | ||
P304 | page(s) | 199-203 | |
P577 | publication date | 2015-12-28 | |
P1433 | published in | Chirality | Q2120255 |
P1476 | title | Chiral Separation of Uncharged Pomalidomide Enantiomers Using Carboxymethyl-β-Cyclodextrin: A Validated Capillary Electrophoretic Method | |
P478 | volume | 28 |
Q39030333 | Chiral selectors in CE: Recent development and applications (mid-2014 to mid-2016). |
Q47763989 | Enantioselective resolution of 4-chloromandelic acid by liquid-liquid extraction using 2-chloro-N-carbobenzyloxy-L-amino acid. |
Q50881127 | Validated capillary electrophoretic method for the enantiomeric quality control of R-praziquantel. |
Search more.